Clotrimazole
/api/v1/drug/clotrimazoleMechanism of action
Sourced from openFDAMechanism-of-action class: Squalene Monooxygenase Inhibitors.
Indications
Sourced from openFDA- Uses Cures athlete’s foot (tinea pedis), jock itch (tinea cruris), ringworm (tinea corporis). Relieves the itching, irritation, redness, scaling and discomfort which can accompany these conditions.ICD-10: B35.3
Dosage & administration
Sourced from openFDADirections • Wash the affected area and dry thoroughly. ● Apply a thin layer of this product over affected area twice daily (morning and night), or as directed by a doctor. ● Supervise children in the use of this product. ● For athlete’s foot, pay special attention to the spaces between the toes; wear well-fitting ventilated shoes, and change shoes and socks at least once daily. ● For athlete’s foot and ringworm, use daily for 4 weeks. For jock itch, use daily for 2 weeks. ● If conditions persists longer, consult a doctor. ● This product is not effective on the scalp or nails.
Warnings & precautions
Sourced from openFDAFor External use only.
Approval history
Sourced from openFDA- Jul 16, 1993ANDAANDA074165P And L
- Aug 31, 1993ANDAANDA072640Sun Pharma Canada
- Dec 4, 1995ANDAANDA072641Sun Pharma Canada
- Jul 29, 1996ANDAANDA074580Sun Pharma Canada
- Apr 12, 2000NDANDA021143Sun Pharma Canada
- May 29, 2001ANDAANDA075673Taro
- Jun 5, 2001ANDAANDA075502Fougera Pharms
- Sep 26, 2025NDANDA217628Carwin Pharm Assoc
FAERS reports
- 1Drug Ineffective1,40611%
- 2Nausea8707.0%
- 3Pain8296.6%
- 4Macular Degeneration8056.5%
- 5Headache7686.2%
- 6Off Label Use7666.1%
- 7Dyspnoea7646.1%
- 8Fatigue7145.7%
- 9Diarrhoea6435.2%
- 10Pyrexia5534.4%
- 11Malaise5014.0%
- 12Rash4994.0%
- 13Weight Decreased4903.9%
- 14Anxiety4793.8%
- 15Chronic Kidney Disease4753.8%
Literature
Recent PubMed references pinned to Clotrimazole as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.
- Clotrimazole-Mediated Autophagy to Protect Against Cisplatin-Induced Ototoxicity via the AMPK/mTOR/TFEB Pathway in Mice.Antioxidants & redox signaling · 2026 · Jiang Y, Li Z, Dong W, et al.PMID 42049637DOI 10.1177/15230864261443785
- Antifungal resistance and Ocimum gratissimum L. essential oil-clotrimazole interactions in clinical Candida isolates from Vietnam.Future microbiology · 2026 · Tuan DA, Masak JPMID 42047035DOI 10.1080/17460913.2026.2665051
- Clotrimazole-loaded PLGA microparticles for local drug delivery to the vagina: Shape does matter.Animal models and experimental medicine · 2026 · Li Y, Luo J, Zou S, et al.PMID 41943392DOI 10.1002/ame2.70198
- Design and optimization of the surfactant mixture ratio for oleic acid-based ophthalmic nanoemulsions prepared by the HPH technology - feasibility study for clotrimazole as a model drug.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 2026 · Gawin-Mikołajewicz A, Malec KH, Marciniak DM, et al.PMID 41903825DOI 10.1016/j.ejpb.2026.115063
- Contrasting selective signatures of gene expression plasticity in response to antifungal clotrimazole and common environmental stresses in yeast.Nature communications · 2026 · Qian Y, Yao Z, Yao Y, et al.PMID 41876564DOI 10.1038/s41467-026-71153-0
- Dissolving Microneedles Loaded with Lipid Nanocarriers for Vaginal Delivery of Clotrimazole: In Vitro and Ex Vivo Evaluation.Molecular pharmaceutics · 2026 · Udayakumar P, Škalko-Basnet N, Rondahl V, et al.PMID 41834717DOI 10.1021/acs.molpharmaceut.5c01721
- Candida vulvovaginitis treatment: A comparative clinical trial of clotrimazole and prangos ferulacea (Jashir) vaginal creams.Complementary therapies in medicine · 2026 · Ghiasi L, Goudarzi F, Sadeghi H, et al.PMID 41765149DOI 10.1016/j.ctim.2026.103334
- Dual-active clotrimazole-methyl eugenol topical gel: in vitro antibiofilm activity against Candida spp. and benchmarking versus commercial topical antifungals.Journal of applied microbiology · 2026 · Tuan DA, Masak JPMID 41528322DOI 10.1093/jambio/lxag015
Clinical trials
The 10 most recently updated of 146 ClinicalTrials.gov registrations naming Clotrimazole as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.
- Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal TherapyRecruiting · Phase 2 · Interventional · 60 enrolled · Elion Therapeutics, Inc.NCT07215273updated 2026-06-09
- Vertebral Bone Marrow Clot for Spinal SurgeryActive not recruiting · Interventional · 96 enrolled · Istituto Ortopedico RizzoliNCT05947175updated 2026-05-27
- A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.Recruiting · Phase 3 · Interventional · 450 enrolled · Basilea PharmaceuticaNCT05421858updated 2026-05-20
- Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX OverexpressionRecruiting · Phase 1 · Phase 2 · Interventional · 84 enrolled · AstraZenecaNCT07155226updated 2026-05-19
- Phase III Efficacy and Safety Study of Miconazole Oil for OtomycosisCompleted · Phase 3 · Interventional · 112 enrolled · Hill Dermaceuticals, Inc.NCT05660382updated 2026-05-12
- Methods of T Cell Depletion Trial (MoTD)Recruiting · Phase 2 · Interventional · 400 enrolled · University of BirminghamNCT04888741updated 2026-05-05
- Improving the Care of Incontinence-Associated Dermatitis (IAD) Using a Beta-Glucan Cream as a Hydrating and Soothing AgentNot yet recruiting · Interventional · 60 enrolled · University of AlbertaNCT07524439updated 2026-04-28
- Determining Elements of Anti-Fungal Immunity in BURN PatientsRecruiting · Observational · 327 enrolled · Assistance Publique - Hôpitaux de ParisNCT06828458updated 2026-04-23
- Comparative Efficacy of Topical Clotrimazole Versus 2% Salicylic Acid in OtomycosisCompleted · Interventional · 60 enrolled · Mayo Hospital LahoreNCT07535424updated 2026-04-17
- Geriatric Assessment & Genetic Profiling to Personalize Therapy in Older Adults With Acute Myeloid LeukemiaCompleted · Phase 2 · Interventional · 75 enrolled · University of NebraskaNCT03226418updated 2026-03-10
Frequently asked questions
- How does Clotrimazole work?
- Mechanism-of-action class: Squalene Monooxygenase Inhibitors.
- What is Clotrimazole used for?
- According to FDA labeling, Clotrimazole carries indications including: Uses Cures athlete’s foot (tinea pedis), jock itch (tinea cruris), ringworm (tinea corporis). Relieves the itching, irritation, redness, scaling and discomfort which can accompany these conditions.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
- What class of drug is Clotrimazole?
- Clotrimazole is classified as Antiinfectives and antiseptics for local oral treatment, Imidazole and triazole derivatives, Imidazole derivatives, Azole Antifungal, Squalene Monooxygenase Inhibitors, Decreased Cell Wall Integrity.
- What are the brand names for Clotrimazole?
- Clotrimazole is marketed under brand names including Aardora Anti-Fungal Maximum Strength, Alevazol, Clotic, Cruex Antifungal, Dermatin, Fungicure Solution, Fungistat, Jock-Eze.
clotrimazole is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.